Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1776)
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
3,399
Price
$153.40
Total Value
$521.42K
Shares Held After
964,652
% of Holdings
0.4%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
6,644
Price
$152.21
Total Value
$1.01M
Shares Held After
968,051
% of Holdings
0.7%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
2,440
Price
$151.46
Total Value
$369.57K
Shares Held After
974,695
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
20,000
Price
$38.27
Total Value
$765.47K
Shares Held After
73,969
% of Holdings
21.3%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
14,493
Price
$38.56
Total Value
$558.81K
Shares Held After
10,500
% of Holdings
58.0%
Pharvaris N.V. (PHVS)
Bjork Elisabeth — Director
Shares
52,500
Price
$37.89
Total Value
$1.99M
Shares Held After
15,167
% of Holdings
77.6%
Hims&Hers Health, Inc. (HIMS)
Okupe Oluyemi — Chief Financial Officer
Shares
12,313
Price
$28.82
Total Value
$354.86K
Shares Held After
251,804
% of Holdings
4.7%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
645
Price
$81.09
Total Value
$52.30K
Shares Held After
809,631
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
6,855
Price
$80.52
Total Value
$551.96K
Shares Held After
810,276
% of Holdings
0.8%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
11,609
Price
$81.09
Total Value
$941.37K
Shares Held After
14,985,469
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
123,391
Price
$80.52
Total Value
$9.94M
Shares Held After
14,997,078
% of Holdings
0.8%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
4,942
Price
$81.09
Total Value
$400.75K
Shares Held After
8,602,783
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
52,558
Price
$80.52
Total Value
$4.23M
Shares Held After
8,607,725
% of Holdings
0.6%
Tempus AI, Inc. (TEM)
Bartolucci Ryan M — Chief Accounting Officer
Shares
7,062
Price
$75.00
Total Value
$529.65K
Shares Held After
60,804
% of Holdings
10.4%
Tempus AI, Inc. (TEM)
Polovin Andrew — EVP, Chief Legal Officer
Shares
2,951
Price
$75.00
Total Value
$221.32K
Shares Held After
135,189
% of Holdings
2.1%
Heartflow, Inc. (HTFL)
Verghese Vikram — Chief Financial Officer
Shares
7,579
Price
$50.11
Total Value
$379.82K
Shares Held After
171,949
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$501.60
Total Value
$80.26K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
468
Price
$500.09
Total Value
$234.04K
Shares Held After
324,603
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
332
Price
$499.10
Total Value
$165.70K
Shares Held After
325,071
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
151
Price
$497.79
Total Value
$75.17K
Shares Held After
325,403
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,953
Price
$497.17
Total Value
$970.98K
Shares Held After
325,554
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,182
Price
$496.21
Total Value
$1.08M
Shares Held After
327,507
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,905
Price
$495.11
Total Value
$943.18K
Shares Held After
329,689
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,750
Price
$494.34
Total Value
$865.10K
Shares Held After
331,594
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
599
Price
$493.22
Total Value
$295.44K
Shares Held After
333,344
% of Holdings
0.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
34,000
Price
$98.60
Total Value
$3.35M
Shares Held After
519,209
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
320
Price
$501.58
Total Value
$160.51K
Shares Held After
45,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
125
Price
$500.80
Total Value
$62.60K
Shares Held After
45,492
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,160
Price
$499.75
Total Value
$579.71K
Shares Held After
45,617
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
843
Price
$498.74
Total Value
$420.44K
Shares Held After
46,777
% of Holdings
1.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
700
Price
$104.39
Total Value
$73.07K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,400
Price
$497.54
Total Value
$696.56K
Shares Held After
47,620
% of Holdings
2.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
1,100
Price
$103.20
Total Value
$113.52K
Shares Held After
700
% of Holdings
61.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
2,873
Price
$496.58
Total Value
$1.43M
Shares Held After
49,020
% of Holdings
5.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
3,501
Price
$102.39
Total Value
$358.47K
Shares Held After
1,800
% of Holdings
66.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,579
Price
$495.97
Total Value
$783.13K
Shares Held After
51,893
% of Holdings
3.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
6,771
Price
$101.37
Total Value
$686.38K
Shares Held After
5,301
% of Holdings
56.1%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
7,928
Price
$100.43
Total Value
$796.21K
Shares Held After
12,072
% of Holdings
39.6%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
376
Price
$68.45
Total Value
$25.74K
Shares Held After
1,296,594
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
9,624
Price
$67.83
Total Value
$652.80K
Shares Held After
1,296,970
% of Holdings
0.7%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
800
Price
$43.00
Total Value
$34.40K
Shares Held After
13,115
% of Holdings
5.7%
TELA Bio, Inc. (TELA)
Capper Joseph H — Director
Shares
25,000
Price
$1.22
Total Value
$30.53K
Shares Held After
179,827
% of Holdings
13.9%
Alignment Healthcare, Inc. (ALHC)
KONOWIECKI JOSEPH S — Director
Shares
23,511
Price
$8.61
Total Value
$202.43K
Shares Held After
1,080,305
% of Holdings
2.1%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
1,921
Price
$4.56
Total Value
$8.76K
Shares Held After
2,803,446
% of Holdings
0.1%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
24,000
Price
$0.21
Total Value
$4.99K
Shares Held After
126,822
% of Holdings
18.9%
ICON PLC (ICLR)
McCague Eugene Pacelli — Director
Shares
3,255
Price
$175.00
Total Value
$569.62K
Shares Held After
3,811
% of Holdings
46.1%
ICON PLC (ICLR)
Murphy Ronan Martin — Director
Shares
5,005
Price
$175.00
Total Value
$875.88K
Shares Held After
3,847
% of Holdings
56.5%
908 Devices Inc. (MASS)
Kenneweg John — SVP, Sales&Product Marketing
Shares
5,257
Price
$10.22
Total Value
$53.73K
Shares Held After
57,784
% of Holdings
8.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
6,802
Price
$64.95
Total Value
$441.80K
Shares Held After
432,886
% of Holdings
1.5%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
101,691
Price
$64.59
Total Value
$6.57M
Shares Held After
439,688
% of Holdings
18.8%
Showing 1–50 of 1776 transactions (page 1 of 36)